Insilico and Bora sign AI drug discovery pact worth up to $2.5B

On July 15, 2026, Insilico Medicine announced a multi-target AI drug discovery and development collaboration with Bora Pharmaceuticals that could be worth up to $2.5 billion. The partnership combines Insilico’s Pharma.AI platform with Bora’s development and manufacturing capabilities to generate and advance novel drug candidates.([fiercepharma.com](https://www.fiercepharma.com/pharma/insilico-signs-cdmo-bora-25b-ai-drug-discovery-deal?utm_source=openai))